Literature DB >> 19304659

Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.

Ersheng Kuang1, Fayi Wu, Fanxiu Zhu.   

Abstract

As obligate intracellular parasites, viruses exploit diverse cellular signaling machineries, including the mitogen-activated protein-kinase pathway, during their infections. We have demonstrated previously that the open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus interacts with p90 ribosomal S6 kinases (RSKs) and strongly stimulates their kinase activities ( Kuang, E., Tang, Q., Maul, G. G., and Zhu, F. (2008) J. Virol. 82, 1838-1850 ). Here, we define the mechanism by which ORF45 activates RSKs. We demonstrated that binding of ORF45 to RSK increases the association of extracellular signal-regulated kinase (ERK) with RSK, such that ORF45, RSK, and ERK formed high molecular mass protein complexes. We further demonstrated that the complexes shielded active pERK and pRSK from dephosphorylation. As a result, the complex-associated RSK and ERK were activated and sustained at high levels. Finally, we provide evidence that this mechanism contributes to the sustained activation of ERK and RSK in Kaposi sarcoma-associated herpesvirus lytic replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304659      PMCID: PMC2679495          DOI: 10.1074/jbc.M900025200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  MAPK signal specificity: the right place at the right time.

Authors:  Leon O Murphy; John Blenis
Journal:  Trends Biochem Sci       Date:  2006-04-17       Impact factor: 13.807

2.  RSK and MSK in MAP kinase signalling.

Authors:  Camilla Hauge; Morten Frödin
Journal:  J Cell Sci       Date:  2006-08-01       Impact factor: 5.285

Review 3.  MAPK phosphatases--regulating the immune response.

Authors:  Yusen Liu; Edward G Shepherd; Leif D Nelin
Journal:  Nat Rev Immunol       Date:  2007-03       Impact factor: 53.106

4.  Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis.

Authors:  Fan Xiu Zhu; Xiaojuan Li; Fuchun Zhou; Shou-Jiang Gao; Yan Yuan
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Inhibition of ERK-MAP kinase signaling by RSK during Drosophila development.

Authors:  Myungjin Kim; Jun Hee Lee; Hyongjong Koh; Soo Young Lee; Cholsoon Jang; Cecilia J Chung; Jung Hwan Sung; John Blenis; Jongkyeong Chung
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

6.  Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Patrick W Ford; Benjaman A Bryan; Ossie F Dyson; Douglas A Weidner; Vishnu Chintalgattu; Shaw M Akula
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

7.  Suppression of coronavirus replication by inhibition of the MEK signaling pathway.

Authors:  Yingyun Cai; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Adina Cohen; Chaya Brodie; Ronit Sarid
Journal:  J Gen Virol       Date:  2006-04       Impact factor: 3.891

10.  BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.

Authors:  Gopal P Sapkota; Lorna Cummings; Felicity S Newell; Christopher Armstrong; Jennifer Bain; Morten Frodin; Matthias Grauert; Matthias Hoffmann; Gisela Schnapp; Martin Steegmaier; Philip Cohen; Dario R Alessi
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

View more
  38 in total

1.  ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Shumin Du; Denis Avey; Yuqing Li; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.

Authors:  H M Abdullah Al Masud; Takahiro Watanabe; Masahiro Yoshida; Yoshitaka Sato; Fumi Goshima; Hiroshi Kimura; Takayuki Murata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Lu Huang; Yunjun Xiao; Xiangyang Yao; Xubing Long; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

4.  Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.

Authors:  Brian S Bowser; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

Review 5.  Modulation of the Translational Landscape During Herpesvirus Infection.

Authors:  Britt A Glaunsinger
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

6.  Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.

Authors:  Moritz Hentschke; Laura Berneking; Cristina Belmar Campos; Friedrich Buck; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

7.  Identification and characterization of two novel spliced genes located in the orf47-orf46-orf45 gene locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  Pey-Jium Chang; Chien-Hui Hung; Shie-Shan Wang; Ping-Hsin Tsai; Ying-Ju Shih; Li-Yu Chen; Hsiao-Yun Huang; Ling-Huei Wei; Ju-Bei Yen; Chun-Liang Lin; Lee-Wen Chen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

8.  Distinct roles for extracellular signal-regulated kinase 1 (ERK1) and ERK2 in the structure and production of a primate gammaherpesvirus.

Authors:  Evonne N Woodson; Dean H Kedes
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

9.  Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.

Authors:  Denis Avey; Sarah Tepper; Benjamin Pifer; Amritpal Bahga; Hunter Williams; Joseph Gillen; Wenwei Li; Sarah Ogden; Fanxiu Zhu
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

Authors:  Henry H Chang; Don Ganem
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.